Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
The Baldwin Group $935 million credit facilities financing
We advised the borrower on the refinancing and amendment
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction
Precigen $79 million preferred stock and warrants offering
We advised Precigen on the private placement
VersaBank $75 million follow-on offering
The common shares are dual-listed on the Nasdaq Global Select Market and the Toronto Stock Exchange
Hertz $500 million senior notes offering and concurrent consent solicitations
We advised Hertz on the transactions
Shyft Group merger with Aebi Schmidt Group
We are advising Shyft Group on the transaction
Sabre $800 million exchange offer and $775 million term loan exchange
We are advising Sabre on the exchange offers